Avanos Medical Inc Cash Flow Conversion Efficiency
Avanos Medical Inc cash flow conversion efficiency. Based on the latest financial reports, Avanos Medical Inc (AVNS) has a cash flow conversion efficiency ratio of -0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.30 Million) by net assets ($782.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Avanos Medical Inc (2011–2025)
Cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025. This chart illustrates how Avanos Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Avanos Medical Inc stock price for real-time trading data and today's change.
Avanos Medical Inc Cash Flow Conversion Ratio Explained
Avanos Medical Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Avanos Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avanos Medical Inc ranked by their cash flow conversion efficiency. Also see Avanos Medical Inc (AVNS) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Televisa S.A.B.
F:TLV
|
0.100x |
|
NCR Voyix Corporation
NYSE:VYX
|
0.052x |
|
MRC Global Inc
NYSE:MRC
|
-0.070x |
|
Central Reinsurance Corp
TW:2851
|
0.050x |
|
The India Cements Limited
NSE:INDIACEM
|
-0.019x |
|
Cibus Nordic Real Estate AB (publ)
ST:CIBUS
|
0.041x |
|
El Puerto de Liverpool S.A.B. de C.V
MX:LIVEPOLC-1
|
0.012x |
|
Shenzhen Fine Made Electronics Group Co Ltd
SHE:300671
|
-0.022x |
Annual Cash Flow Conversion Efficiency for Avanos Medical Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Avanos Medical Inc from 2011 to 2025. Review free cash flow generation of Avanos Medical Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $778.20 Million | $74.70 Million | 0.096x | -21.02% |
| 2024-12-31 | $828.50 Million | $100.70 Million | 0.122x | +363.78% |
| 2023-12-31 | $1.24 Billion | $32.40 Million | 0.026x | -62.77% |
| 2022-12-31 | $1.29 Billion | $90.90 Million | 0.070x | +2.46% |
| 2021-12-31 | $1.27 Billion | $87.30 Million | 0.069x | +3553.25% |
| 2020-12-31 | $1.26 Billion | $-2.50 Million | -0.002x | +96.62% |
| 2019-12-31 | $1.27 Billion | $-74.50 Million | -0.059x | +47.54% |
| 2018-12-31 | $1.30 Billion | $-145.60 Million | -0.112x | -194.60% |
| 2017-12-31 | $1.22 Billion | $144.20 Million | 0.119x | -30.72% |
| 2016-12-31 | $1.10 Billion | $188.80 Million | 0.171x | +85.16% |
| 2015-12-31 | $1.06 Billion | $97.60 Million | 0.092x | -6.75% |
| 2014-12-31 | $1.49 Billion | $147.90 Million | 0.099x | -7.86% |
| 2013-12-31 | $2.08 Billion | $223.80 Million | 0.108x | +9.22% |
| 2012-12-31 | $2.06 Billion | $202.60 Million | 0.099x | -- |
| 2011-12-31 | $0.00 | $139.60 Million | x | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more